Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2003
09/25/2003US20030181420 Modulators of LXR
09/25/2003US20030180635 Visible radiation sensitive composition
09/25/2003US20030180305 Pharmaceuticals for the imaging of angiogenic disorders
09/25/2003US20030177591 Method of dyeing keratin-containing fibers
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2479141A1 Pyridone derivatives
09/25/2003CA2479069A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478540A1 Indazoles substituted with an anti-cancerous activity
09/25/2003CA2478534A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003CA2478172A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003CA2477906A1 Process for making chiral 1,4-disubstituted piperazines
09/24/2003EP1346992A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1346983A2 Phthalimido arylpiperazines as alpha 1A receptor antagonists useful in the treatment of benign prostatic hyperplasia
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345930A2 Pharmaceutical compounds
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345924A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345923A1 Azinyl sulfonylimidazoles for use as microbicidal agents
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345921A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
09/24/2003EP1345901A2 Process for making amlodipine, derivatives thereof, and precursors therefor
09/24/2003EP1345900A1 Guanidine and amidine derivatives as factor xa inhibitors
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1224186B1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/24/2003EP1178965B1 Quinoline derivatives as inhibitors of mek enzymes
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0973746B1 Substituted 3-cyano quinolines
09/24/2003EP0944618B1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
09/24/2003CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1444480A Highly absorbable solid preparation
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1443763A Internediate for preparing quinoxaline diketone
09/24/2003CN1122031C Substituted benzocycloheptapyridine derivatives useful for inhibitino of farnesyl protein transferase
09/24/2003CN1122022C Substituted oximes as neurokinin antagonists
09/24/2003CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension
09/23/2003USRE38257 Piperdine derivatives and hypotensives containing the same
09/23/2003US6624306 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
09/23/2003US6624305 Reacting a 6H-imidazo(4,5-c) tetrazolo(1,5-a)quinoline with triphenylphosphine and hydrolyzing
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
09/23/2003US6624175 4-heterocyclic substituted quinoline derivative treats disorderes associated with pathogenic neurokinin-3 receptor, such as anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder or pain
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624166 Pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta protease activity in a mammal utilizing the compounds and compositions for enzyme inhibitors
09/23/2003CA2275527C Novel heterocyclic substituted pyrrolidine amide derivatives
09/18/2003WO2003076938A1 Novel fluorescent label compounds
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076431A1 Benzimidazole-derivatives for the treatment of sexual dysfunction
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076429A2 Azepane derivatives and their use as atk1 inhibitors
09/18/2003WO2003076428A1 Quinolonecarboxylic acid derivative
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076426A2 Pyridinyloxy derivatives as 5-ht receptor ligands
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003076408A2 Indazole derivatives that are activators of soluble guanylate cyclase
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076403A1 1,2-disubstituded-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075926A1 Use of proton pump inhibitors for the treatment of airway disorders
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003051848A3 Imidazolidineacetic acid derivatives
09/18/2003WO2003051838A3 Protein kinase inhibitors